Setting the Stage for Success: PRISM MarketView Highlights Soligenix's Promising HyBryte™ Replication Trial Setting the Stage for Success: PRISM MarketView Highlights Soligenix's Promising HyBryte™ Replication Trial

PRISM MarketView Highlights Soligenix, Inc. as it Builds on Compelling Phase 3 Data with Key Catalysts on the Horizon PRISM MarketView Highlights Soligenix, Inc. as it Builds on Compelling Phase 3 Data with Key Catalysts on the Horizon

UPDATE: New to The Street to Feature Soligenix Appearances on Its Syndicated Televised Outlets NEW YORK, Oct. 17, 2022 (GLOBE NEWSWIRE) -- FMW Media Inc.'s New to The Street is pleased to announce that Soligenix, Inc. (Nasdaq: SNGX), a late-stage biopharmaceutical company focused on...

New to The Street to Feature Soligenix Appearances on Its Syndicated Televised Outlets NEW YORK, Oct. 17, 2022 (GLOBE NEWSWIRE) -- FMW Media Inc.'s New to The Street is pleased to announce that Soligenix, Inc. (Nasdaq: SNGX), a late-stage biopharmaceutical company focused on...